Literature DB >> 33436689

Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid.

Rosa M Coco-Martin1,2, Cristina Andrés-Iglesias3, Girish K Srivastava1, Javier Lagos-Rodriguez4, Miguel Ruiz-Tevah5, Mario R Díaz-Cárdenas6, Ivan Fernandez-Bueno1, Juan García-Serna7, María T García-Gutierrez1, Alfredo García-Layana2,8, J Carlos Pastor1,2,9.   

Abstract

Serious intraocular toxicity cases have been reported worldwide after the use of different perfluorocarbon liquids. The current study reports for the first-time the clinical pictures of cases of acute intraocular toxicity caused by MEROCTANE, a perfluoro-octane commercialized by a Turkish company and distributed in many countries. A series of 18 cases from Chile and Spain was retrospectively analysed. To evaluate the impurity profile, a suspicious MEROCTANE sample (lot OCT.01.2013) was analysed by gas chromatography mass spectrometry and compared with a non-suspicious sample of the same commercial perfluoro-octane (lot OCT 722011). Cytotoxicity was tested following a direct-contact method, taking into consideration the high volatility and hydrophobicity of perfluoro-octane and following the ISO 10993 guideline. Cytotoxicity test showed clear cytotoxic effects of the analysed batch (less than 9% of cell viability). Moreover, chemical analysis demonstrated the presence of many contaminants, some highly toxic (acids and alcohols). Perfluorocarbon liquids are useful tools for intraocular surgery but companies and Agencies of Medical Devices must implement measures that guarantee the safety of these products based on both chemical and cytotoxicity analysis for every batch. Medical staff should be encouraged to report any suspected case to their respective National Agencies.

Entities:  

Year:  2021        PMID: 33436689      PMCID: PMC7804266          DOI: 10.1038/s41598-020-79561-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  10 in total

1.  The acute toxicity problem with some perfluorooctanes.

Authors:  J C Pastor Jimeno; R M Coco Martin
Journal:  Arch Soc Esp Oftalmol       Date:  2017-05-27

2.  Chorioretinal Toxicity Of The Perfluorooctane Ala® Octa: Results From 48 Surgical Procedures In Geneva.

Authors:  Stéphan Tobalem; Andreas Weinberger; Martina Kropp; Ariane Malcles; Christian Jonescu-Cuypers; Georges Souteyrand; Gabriele Thumann
Journal:  Am J Ophthalmol       Date:  2020-05-20       Impact factor: 5.258

3.  Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: failure of another indirect cytotoxicity analysis.

Authors:  Rosa M Coco; Girish K Srivastava; Cristina Andrés-Iglesias; Jesús Medina; Fernando Rull; Alvaro Fernandez-Vega-Gonzalez; Ivan Fernandez-Bueno; Antonio Dueñas; Jose C Pastor
Journal:  Br J Ophthalmol       Date:  2018-03-29       Impact factor: 4.638

4.  ACUTE RETINAL DAMAGE AFTER USING A TOXIC PERFLUORO-OCTANE FOR VITREO-RETINAL SURGERY.

Authors:  J Carlos Pastor; Rosa M Coco; Ivan Fernandez-Bueno; Maria L Alonso-Alonso; Jesús Medina; Aurelio Sanz-Arranz; Fernando Rull; Manuel J Gayoso; Antonio Dueñas; Maria T Garcia-Gutierrez; Lucia Gonzalez-Buendia; Santiago Delgado-Tirado; Emilio Abecia; Miguel Ruiz-Miguel; Miguel A Serrano; Jose M Ruiz-Moreno; Girish K Srivastava
Journal:  Retina       Date:  2017-06       Impact factor: 4.256

5.  Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery.

Authors:  Girish K Srivastava; Cristina Andrés-Iglesias; Rosa M Coco; Ivan Fernandez-Bueno; Jesús Medina; Juan García-Serna; Antonio Dueñas; Fernando Rull; J Carlos Pastor
Journal:  Regul Toxicol Pharmacol       Date:  2019-11-14       Impact factor: 3.271

6.  Hydrofluoric Acid and Other Impurities in Toxic Perfluorooctane Batches.

Authors:  Dirk-Henning Menz; Nicolas Feltgen; Thorsten Lechner; Helge Menz; Bernd-Kristof Müller; Joachim Dresp; Hans Hoerauf
Journal:  Transl Vis Sci Technol       Date:  2019-05-29       Impact factor: 3.283

7.  BLINDNESS RELATED TO PRESUMED RETINAL TOXICITY AFTER USING PERFLUOROCARBON LIQUID DURING VITREORETINAL SURGERY.

Authors:  Silvia Méndez-Martínez; Pilar Calvo; Nelson Arturo Rodriguez-Marco; Fernando Faus; Emilio Abecia; Luis Pablo
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

Review 8.  Retinal Toxicity of Medical Devices Used during Vitreoretinal Surgery: A Critical Overview.

Authors:  Kai Januschowski; Cristina Irigoyen; J Carlos Pastor; Girish K Srivastava; Mario R Romano; Heinrich Heimann; Peter Stalmans; Karel Van Keer; Karl Boden; Peter Szurman; Martin S Spitzer
Journal:  Ophthalmologica       Date:  2018-07-12       Impact factor: 3.250

9.  Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation.

Authors:  Girish K Srivastava; Maria L Alonso-Alonso; Ivan Fernandez-Bueno; Maria T Garcia-Gutierrez; Fernando Rull; Jesús Medina; Rosa M Coco; J Carlos Pastor
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

10.  H-Content Is Not Predictive of Perfluorocarbon Ocular Endotamponade Cytotoxicity in Vitro.

Authors:  Paolo Ruzza; Claudio Gatto; Eugenio Ragazzi; Mario R Romano; Claudia Honisch; Jana D'Amato Tóthová
Journal:  ACS Omega       Date:  2019-08-02
  10 in total
  2 in total

Review 1.  [Visual acuity reduction and silicone oil tamponade].

Authors:  Armin Wolf; Mario R Romano; Christos Haritoglou
Journal:  Ophthalmologie       Date:  2022-08-02

Review 2.  Acute intraocular toxicity caused by perfluorocarbon liquids: safety control systems of medical devices.

Authors:  Girish K Srivastava; Vivekanandan Kalaiselvan; Cristina Andrés-Iglesias; Shatrunajay Shukla; Rohit Saxena; Jose Carlos Pastor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-05       Impact factor: 3.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.